A recommendation to use a factor Xa inhibitor first line for the treatment of acute VTE is one of the key features of new Australasian guidelines. Released by Thrombosis and Haemostasis Society of Australia and New Zealand (THANZ) this week, the new guidelines recommend that most patients with acute VTE should be treated with an ...
Use DOACs first line for acute VTE treatment, new guidelines advise
By Michael Woodhead
14 Feb 2019